Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.
Kirsten DahlAshley BrooksFiras AlmazediSøren Tetens HoffCristina BoschiniTine A BaekdalPublished in: Diabetes, obesity & metabolism (2021)
Oral semaglutide significantly improved fasting and postprandial glucose and lipid metabolism, and delayed gastric emptying.